1-3 of 3
Burkhard Otremba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prophylactic Biosimilar Filgrastim Treatment during Cytotoxic Chemotherapy in Patients with Malignant Diseases: The Venice Observational Study

Burkhard Otremba, MD, Wolfhard Erdlenbruch, MD
Journal: Blood
Blood (2015) 126 (23): 2215.
https://doi.org/10.1182/blood.V126.23.2215.2215
Published: 2015
Journal Articles

Final Results of a Prospective, Non-Interventional Study on Bortezomib (Velcade®, VEL) in the Treatment of Multiple Myeloma (MM) in Office-Based Hematology Units (OBH).

Wolfgang Ulrich Knauf, MD, Burkhard Otremba, MD, Friedrich Overkamp, MD, Susanne Bammer, PhD, Ralf Angermund, MD
Journal: Blood
Blood (2006) 108 (11): 5109.
https://doi.org/10.1182/blood.V108.11.5109.5109
Published: 2006
Journal Articles

Safety and Cost Effectiveness of a 10 × 10 9 /L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 10 9 /L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

Hannes Wandt, Markus Frank, Gerhard Ehninger, Christiane Schneider, Norbert Brack, Ali Daoud, Irene Fackler-Schwalbe, Jürgen Fischer, Ringfried Gäckle, Thomas Geer, Peter Harms, Birgit Löffler, Siegfried Öhl, Burkhard Otremba, Monika Raab, Petra Schönrock-Nabulsi, Gerhard Strobel, Rolf Winter, Hartmut Link
Journal: Blood
Blood (1998) 91 (10): 3601–3606.
https://doi.org/10.1182/blood.V91.10.3601
Published: 1998